Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related VECO
Veeco Instrument Shares Get Upgrade At Summit Following Aixtron Sale News
Benzinga's Top Upgrades
Related UTHR
Stocks Hitting 52-Week Lows
United Therapeutics Says Informed by Medtronics that FDA issued Response Letter Indicating PMA is Not Approvable; UTHR Expects FDA Action in 2016 Regarding NDA Seeking FDA Approval of New Labeling for Remodulin
Why Is It A Good Time To Buy United Therapeutics Corporation? (Seeking Alpha)

Analysts at B. Riley downgraded Veeco Instruments (NASDAQ: VECO) from “buy” to “neutral.” Veeco's shares closed at $30.55 yesterday. Veeco's trailing-twelve-month ROA is 5.44%.

Analysts at Goldman Sachs downgraded United Therapeutics (NASDAQ: UTHR) from “neutral” to “sell.” United Therapeutics' shares closed at $52.16 yesterday. United Therapeutics' trailing-twelve-month ROE is 24.64%.

Analysts at Jefferies downgraded Nabors Industries (NYSE: NBR) from “hold” to “underperform.” Nabors Industries' shares closed at $14.53 yesterday. Nabors Industries' trailing-twelve-month profit margin is 0.44%.

Keefe Bruyette downgraded Comerica (NYSE: CMA) from “market perform” to “underperform.” Comerica's shares closed at $29.27 yesterday. Comerica's PEG ratio is 0.95.

Latest Ratings for VECO

DateFirmActionFromTo
Apr 2016Summit ResearchUpgradesSellHold
Feb 2016Summit ResearchDowngradesHoldSell
Feb 2016Deutsche BankMaintainsHold

View More Analyst Ratings for VECO
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CMA + NBR)

View Comments and Join the Discussion!